Reglan and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reglan (metoclopramide hydrochloride) and Vimpat (lacosamide). Common drug interactions include sinusitis among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Reglan and Vimpat. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.



On Jul, 09, 2026

43 people who take Reglan and Vimpat together, and have interactions are studied.

Reglan and Vimpat drug interactions.

What are the common drug interactions of Reglan and Vimpat, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Skin exfoliation (removal of the oldest dead skin cells)
  3. Staring (a prolonged gaze or fixed look)
  4. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Thalamus haemorrhage (bleeding in thalamus)
  7. Therapeutic response unexpected
  8. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  9. Unresponsive to stimuli
  10. Vulvovaginal discomfort

male:

  1. Urinary tract infection
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Cough
  4. Abdominal discomfort
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Constipation
  7. Decreased appetite
  8. Fatigue (feeling of tiredness)
  9. Flatulence (flatus expelled through the anus)
  10. Hypertension (high blood pressure)

What are the common drug interactions of Reglan and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Swelling
  2. Abdominal discomfort
  3. Cough
  4. Flatulence (flatus expelled through the anus)
  5. Regurgitation (expulsion of material)
  6. Sedation
  7. Vomiting
  8. Impaired gastric emptying
  9. Rhinovirus infection
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Device failure
  3. Drug ineffective
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

30-39:

  1. Abdominal pain upper

40-49:

  1. Urinary tract infection
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Diarrhoea
  4. Fall
  5. Fungal skin infection
  6. Hypokalaemia (low potassium)
  7. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  8. Urinary tract infection bacterial
  9. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

50-59:

  1. Urinary tract infection
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Confusional state
  4. Addison's disease (addison's disease, a hormonal disorder disease)
  5. Hypersomnia (excessive daytime sleepiness (eds))
  6. Lethargy (tiredness)
  7. Diarrhoea
  8. Fall
  9. Fungal skin infection
  10. Hypokalaemia (low potassium)

60+:

  1. Pyrexia (fever)
  2. Urinary tract infection
  3. Hepatitis a
  4. Hypertension (high blood pressure)
  5. Malignant neoplasm progression (cancer tumour came back)
  6. Pain
  7. Vomiting
  8. Weight decreased
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Feeling hot

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 11 people, 25.58%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 18.60%
  3. Migraine (headache): 7 people, 16.28%
  4. High Blood Pressure: 6 people, 13.95%
  5. Partial Seizures (seizures which affect only a part of the brain at onset): 5 people, 11.63%
  6. Pain: 5 people, 11.63%
  7. Constipation: 5 people, 11.63%
  8. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 5 people, 11.63%
  9. Stress And Anxiety: 5 people, 11.63%
  10. Gout (uric acid crystals building up in the body): 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Reglan and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reglan and Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and lacosamide (the active ingredients of Reglan and Vimpat, respectively), and Reglan and Vimpat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: